[HTML] nature.com

[HTML][HTML] Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

C Phetsouphanh, DR Darley, DB Wilson, A Howe… - Nature …, 2022 - nature.com
A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection
develop post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here …
被引用次数：735 相关文章

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.

C Phetsouphanh, DR Darley, DB Wilson… - Nature …, 2022 - europepmc.org
A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection
develop post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here …
[PDF] archive.org

[PDF][PDF] Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection

C Phetsouphanh, D Darley, A Howe, CML Munier… - scholar.archive.org
A proportion of patients surviving acute COVID-19 infection develop post-COVID syndrome
(long COVID) encompassing physical and neuropsychiatric symptoms lasting longer than 12 …
[PDF] werkcovid19.nl

[PDF][PDF] Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

C Phetsouphanh, DR Darley, DB Wilson, A Howe… - werkcovid19.nl
LETTERS NATUrE ImmUNOLOgy 6.83-fold higher compared to UHCs (Fig. 1a). IFN-λ1 was
increased 2.44-fold and 3.24-fold in the LC and MC groups compared to the HCoV group …

Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection

C Phetsouphanh, D Darley, DB Wilson, A Howe… - 2021 - pesquisa.bvsalud.org
ABSTRACT A proportion of patients surviving acute COVID-19 infection develop post-
COVID syndrome (long COVID) encompassing physical and neuropsychiatric symptoms …
[PDF] researchgate.net

[PDF][PDF] Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection

C Phetsouphanh, D Darley, A Howe, CML Munier… - researchgate.net
A proportion of patients surviving acute COVID-19 infection develop post-COVID syndrome
(long COVID) encompassing physical and neuropsychiatric symptoms lasting longer than 12 …

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

C Phetsouphanh, DR Darley, DB Wilson… - Nature …, 2022 - research.monash.edu
A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection
develop post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here …

Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection

C Phetsouphanh, D Darley, DB Wilson, A Howe… - medRxiv, 2021 - medrxiv.org
A proportion of patients surviving acute COVID-19 infection develop post-COVID syndrome
(long COVID) encompassing physical and neuropsychiatric symptoms lasting longer than 12 …
[HTML] nature.com

[HTML][HTML] Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection

C Phetsouphanh, DR Darley, DB Wilson, A Howe… - Nature …, 2022 - nature.com
A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection
develop post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here …

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.

C Phetsouphanh, DR Darley, DB Wilson, A Howe… - 2022 - ahro.austin.org.au
A proportion of patients surviving acute coronavirus disease 2019 (COVID-19) infection
develop post-acute COVID syndrome (long COVID (LC)) lasting longer than 12 weeks. Here …